In a major advance for understanding and treating idiopathic pulmonary fibrosis (IPF), researchers at Yale School of Medicine and international collaborators have developed an AI system that learns how lung scarring progresses, and proposes drug candidates to stop it.Published in Nature Biomedical Engineering, the tool, called UNAGI (unified in-silico cellular dynamics and drug screening framework), […]
